ProQR Therapeutics
PRQR
PRQR
48 hedge funds and large institutions have $28.6M invested in ProQR Therapeutics in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 17 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
28% less capital invested
Capital invested by funds: $39.8M → $28.6M (-$11.1M)
71% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 17
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
48
Holding in Top 10
–
Calls
$212K
Puts
$56K
Top Buyers
| 1 | +$1.49M | |
| 2 | +$390K | |
| 3 | +$103K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$37.5K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$27.4K |
Top Sellers
| 1 | -$1.4M | |
| 2 | -$300K | |
| 3 | -$112K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$73.1K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$61.3K |